In the future, the therapeutic influence of specific inhibitors on CSCC tumor tissue genesis will be explored by analyzing the effect of USP39-specific acetylation on SIRT7/USP39/FOXM1 positive feedback axis. The gene discussed is FOXM1; the disease is neoplasm.